NICHOLAS TIEU: Open Payments
NPI 1265203889 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,098 in 171 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $1,654 · 2025 $3,098
Food & beverage: $3,028Education: $70
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 58 | $577 |
| Exelixis Inc. | 10 | $298 |
| AstraZeneca Pharmaceuticals LP | 13 | $294 |
| BeOne Medicines USA, Inc. | 4 | $235 |
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| SOBI, INC | 8 | $162 |
| Merck Sharp & Dohme LLC | 6 | $154 |
| SERVIER PHARMACEUTICALS LLC | 6 | $134 |
| PFIZER INC. | 10 | $101 |
| Karyopharm Therapeutics Inc. | 3 | $96 |
Products named: Enhertu, CABOMETYX, IMFINZI, Doptelet, KEYTRUDA, TEVIMBRA, BRUKINSA, DATROWAY.
Industry payments across CA — which companies pay providers there.
